XOMA ROYALTY CORP - XOMA 8 5/8 PERP(NASDAQ:XOMAP) stock News

XOMAP Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

8 days ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

13 days ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.

13 days ago - By: XOMA Royalty Corporation - Mentions: XOMA HLVX

XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.

a month ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference

a month ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference

a month ago - By: XOMA Royalty Corporation - Mentions: XOMA

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA TSBX

XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics

2 months ago - By: Benzinga - Mentions: USPH EBS HAE CCCC ...

12 Health Care Stocks Moving In Thursday's Intraday Session

2 months ago - By: XOMA Royalty Corporation; LAVA Therapeutics N.V. - Mentions: XOMA

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

2 months ago - By: XOMA Royalty Corporation; LAVA Therapeutics N.V. - Mentions: XOMA LVTX

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

2 months ago - By: XOMA Royalty Corporation - Mentions: XOMA HLVX

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

3 months ago - By: XOMA Royalty Corporation; Turnstone Biologics Corp. - Mentions: XOMA

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

3 months ago - By: XOMA Royalty Corporation; Turnstone Biologics Corp. - Mentions: XOMA TSBX

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

3 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Declares Quarterly Preferred Stock Dividends

4 months ago - By: Benzinga - Mentions: RFL HSDT NAOV KZIA ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

4 months ago - By: XOMA Royalty Corporation; BioInvent - Mentions: XOMA

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

4 months ago - By: XOMA Royalty Corporation; BioInvent - Mentions: XOMA

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

5 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements

5 months ago - By: XOMA Royalty Corporation - Mentions: XOMA

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements

5 months ago - By: XOMA Royalty Corporation - Mentions: XOMA